Epicardial Adipose Tissue Volume As a Marker of Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis.
George Athanasios KarpouzasPanteha RezaeianSarah R OrmsethIvana HollanMatthew J BudoffPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Despite similar EATVs in RA patients and controls, EATVs were associated with greater plaque burden and presence of plaques with a noncalcified component and vulnerability features only in RA patients. EAT may be more pathogenic in RA and play a role in early-stage atherosclerosis. Its value as a biomarker of subclinical atherosclerosis and cardiovascular risk in RA warrants further studies.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- early stage
- disease activity
- ejection fraction
- newly diagnosed
- cardiovascular disease
- chronic kidney disease
- ankylosing spondylitis
- coronary artery disease
- heart failure
- squamous cell carcinoma
- systemic lupus erythematosus
- radiation therapy
- type diabetes
- atrial fibrillation
- risk factors
- patient reported outcomes
- lymph node
- left ventricular
- skeletal muscle
- aortic stenosis
- patient reported
- aortic valve